HPRA Drug Safety Newsletter Edition 89

Download: hpra-drug-safety-newsletter-edition-89.pdf 219 KB

 The latest edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support the safe and appropriate use of the following medicines:

Xofigo (radium-223 dichloride) - New restrictions for use

Varenicline (Champix) - Product Information Update - Reports of transient loss of consciousness

Oral Methotrexate - Updates to Product Information

Adverse Reactions Reporting - Update

« Back